Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients – Bloomberg.com
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients Bloomberg.com Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month CNBC Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash CNN LifeMD® to Offer Market-Leading Pricing for GLP-1 GlobeNewswire Novo Nordisk launches introductory self-pay offer for Wegovy® and Ozempic® for $199 […]
Savile Row boss says weight loss drugs having ‘massive repercussions’ on industry
Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season
Macter gaining market share, and diversifying into cosmetics
Macter International Ltd has emerged from the latest results season with a clear message for investors: momentum is back in branded generics, new biologics are scaling, and a bet on consumer beauty is moving from trial to traction. Management says the company is growing faster than the market, based on data from the healthcare data […]
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress the need for independent studies before these treatments can be fully embraced worldwide.
Taking Ozempic? Yale Researchers Say You’ll Handle Alcohol “Differently” and It Could Be Risky
GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating how this dual effect impacts health. Anti-obesity drugs such as semaglutide (Ozempic, Wegovy), are showing potential beyond obesity treatment. Research increasingly suggests that these drugs may help manage alcohol use disorder and alcohol-related liver disease by reducing the desire to […]
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress the need for independent studies before these treatments can be fully embraced worldwide.
Savile Row boss says weight loss drugs are having ‘massive repercussions’ on industry
Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season
Over 170 deaths linked to fat jabs as fears grow over ‘inappropriate use’ of weight loss injections
MORE than 170 deaths have been linked to fat jabs, it has been revealed. Drug watchdogs have received 173 fatal reports related to GLP-1 injections since 2007 — including two adults in their twenties. And there have been 52 deaths reported to the UK’s Medicines and Healthcare products Regulatory Agency since 2024 began. It comes…
Why the new ‘triple G’ weight loss drug is different – and can be highly dangerous
People are risking their health by injecting a highly potent but unapproved weight loss jab called retatrutide, sometimes called the Godzilla of weight loss injections. The compound works in a similar way to licensed slimming medicines, such as Wegovy and Mounjaro, which mimic gut hormones to quell appetite. Retatrutide seems to cause even greater weight […]
How “Food Noise” Destroyed Her Life | Dr. Christle Guevarra
From Thanksgiving Day through Cyber Monday, get 40% off at http://www.cozyearth.com with code DOCTORMIKE. It’s the best deal of the year!” I’ll teach you how to become the media’s go-to expert in your field. Enroll in The Professional’s Media Academy now: https://www.professionalsmediaacademy.com/ Listen to my podcast, The Checkup with Doctor Mike, here: Spotify: https://go.doctormikemedia.com/spotify/CheckUpSpotify Apple […]